English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 912255      在线人数 : 1193
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版

    子社群

    于重元 [19/19]
    劉柯俊 [85/98]
    劉滄梧 [119/125]
    劉界元(2003-2010) [3/3]
    夏和雄(1996-2012) [26/31]
    夏興國 [51/54]
    姜乃榕 [82/94]
    常慧如 [39/44]
    張俊彥 [234/254]
    張光裕 [69/79]
    張憶壽 [103/106]
    張文祥 [52/53]
    張書銘 [89/91]
    彭汪嘉康(1996-2007) [120/126]
    施能耀 [37/43]
    李家惠 [29/29]
    李岳倫 [48/49]
    林素芳 [32/32]
    楊奕馨 [41/42]
    江士昇 [88/90]
    沈哲宏 [14/16]
    洪文俊 [88/88]
    莊雙恩 [82/91]
    蔡坤志 [32/34]
    蔡慧珍 [66/71]
    蘇勇曄 [40/40]
    蘇振良 [24/25]
    郭靜娟 [71/76]
    陳尚鴻 [45/48]
    陳振陽 [72/72]
    陳立宗 [443/510]
    陳美霞(2002-2009) [1/1]
    陳詩政 [2/2]
    陳雅雯 [38/39]
    黃智興 [55/55]
    黃道揚 [26/26]
    丁兆治(2000-2004) [5/5]
    其他 [464/471]
    劉敏(1996-2007) [60/62]
    劉玫英(2004-2006) [2/2]
    吳成文(1996-2008) [53/55]
    曾思文(1997-2007) [4/4]
    李冠德(1997-2004) [4/6]
    林景太(1999-2007) [5/5]
    楊文光(1996-1999) [21/21]
    王全正(1996-2003) [4/4]
    莊聲宏(1997-2004) [11/11]
    詹宗晃(2000-2008) [2/2]
    賴基銘(2004-2008) [41/47]
    阮麗蓉(2000-2006) [6/7]
    陳俊叡(2003-2007) [6/6]
    馬彥英(1997-1999) [1/1]
    黃奇英(2005-2007) [9/10]

    邻近社群


    分子與基因醫學研究所 [921/964]
    生技與藥物研究所 [830/1008]
    生醫工程與奈米醫學研究所 [1214/1334]
    免疫醫學研究中心 [224/236]
    神經及精神醫學研究中心 [782/804]
    細胞及系統醫學研究所 [755/815]
    感染症與疫苗研究所 [1541/1618]
    群體健康科學研究所 [2870/3000]
    國家環境醫學研究所 [1560/1591]
    國家蚊媒傳染病防治研究中心 [102/104]
    高齡醫學暨健康福祉研究中心 [216/224]
    論壇 [2/2]
    生醫資源中心 [7/7]
    研究生培育合作學程 [188/191]
    核心儀器設施中心 [9/9]
    病理核心實驗室 [14/14]
    實驗動物中心 [8/8]
    行政管理部門 [18/18]

    社群统计


    近3年内发表的文件:335(13.91%)
    含全文笔数:2250(93.40%)

    文件下载次数统计
    下载大于0次:2250(100.00%)
    下载大于100次:2250(100.00%)
    全文下载总次数:1615280(30.14%)

    最后更新时间: 2024-12-01 08:22

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目1076-1100 / 2409. (共97页)
    << < 39 40 41 42 43 44 45 46 47 48 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2016-05 Overexpression of regulator of G protein signaling 11 promotes cell migration and associates with advanced stages and aggressiveness of lung adenocarcinoma Oncotarget. 2016 May;7(21):31122-31136.
    2016-05 Overexpression of the PSAT1 gene in nasopharyngeal carcinoma is an indicator of poor prognosis Journal of Cancer. 2016 May;7(9):1088-1094.
    2016-05 Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine Journal of Clinical Oncology. 2016 May;34(15, Suppl.):Meeting Abstract 4126.
    2016-05 Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1: A randomized phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine (gem)-based therapy Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e15740.
    2016-05 Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number 4017.
    2016-05 Quality-adjusted time without symptoms or toxicity (Q-TWiST) of nanoliposomal irinotecan (nal-IRI; MM-398) plus 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone in metastatic pancreatic adenocarcinoma (mPAC) patients (pts) previously treated with Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e15732.
    2016-05 Efficacy of frontline antibiotics therapy in the treatment of Helicobacter pylori-negative gastric low-grade mucosa-associated lymphoid tissue lymphoma Journal of Clinical Oncology. 2016 May;34(15, Suppl. S):Abstract number e19024.
    2016-04-18 NF-kappaB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance Proceedings of the National Academy of Sciences of the United States of America. 2016 Apr 18;113(18):E2526-E2535.
    2016-04 Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: A nationwide cohort study Gut. 2016 Apr;65(4):693-701.
    2016-04 A 16-year experience in treating thyroglossal duct cysts with a “conservative” Sistrunk approach European Archives of Oto-Rhino-Laryngology. 2016 Apr;273(4):1019-1025.
    2016-04 Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion Oncogene. 2016 Apr;35(17):2156-2165.
    2016-04 APC haploinsufficiency coupled with p53 loss sufficiently induces mucinous cystic neoplasms and invasive pancreatic carcinoma in mice Oncogene. 2016 Apr;35(17):2223-2234.
    2016-04 Receipt of life-sustaining treatments for Taiwanese pediatric patients who died of cancer in 2001 to 2010: A retrospective cohort study Medicine. 2016 Apr;95(16):Article number e3461.
    2016-04 Vascular endothelial growth factor-C promotes EGFR-TKIs resistance and cancer stemness via SLUG of non-small cell lung cancer Journal of Thoracic Oncology. 2016 Apr;11(4, Suppl.):S132-133.
    2016-03-26 CSF2 overexpression is associated with STAT5 phosphorylation and poor prognosis in patients with urothelial carcinoma Journal of Cancer. 2016 Mar 26;7(6):711-721.
    2016-03-24 Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction BMC Cancer. 2016 Mar 24;16:Article number 245.
    2016-03-08 EBV reactivation as a target of luteolin to repress NPC tumorigenesis Oncotarget. 2016 Mar 8;7(14):18999-19017.
    2016-03 miR-520h is crucial for DAPK2 regulation and breast cancer progression Oncogene. 2016 Mar 3;35(9):1134-1142.
    2016-03 Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer Oncogene. 2016 May;35(12):1517-1528.
    2016-03 BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder Histopathology. 2016 Mar;68(4):520-532.
    2016-03 Pancreatic tumor progression associated with CD133 overexpression: Involvement of increased TERT expression and epidermal growth factor receptor-dependent Akt activation Pancreas. 2016 Mar;45(3):443-457.
    2016-03 The clinical efficacy and cardiotoxicity of fixed-dose monthly trastuzumab in HER2-positive breast cancer: A single institutional analysis PLoS ONE. 2016 Mar;11(3):Article number e0151112.
    2016-02-10 Gastric microbiota and predicted gene functions are altered after subtotal gastrectomy in patients with gastric cancer Scientific Reports. 2016 Feb 10;6:Article number 20701.
    2016-02 Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial Lancet. 2016 Feb;387(10018):545-557.
    2016-02 Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells RNA. 2016 Feb;22(2):303-315.

    显示项目1076-1100 / 2409. (共97页)
    << < 39 40 41 42 43 44 45 46 47 48 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈